Patients with primary biliary cirrhosis (PBC) frequently experience significant fatigue thought to result from as-yet-unidentified central nervous system (CNS)-mediated processes. Pilot studies have suggested that autonomic dysfunction is a frequent occurrence in PBC and may contribute to the pathogenesis of this fatigue. The degree to which autonomic dysfunction affects the PBC population as a whole, and its interrelationship with other symptoms experienced by PBC patients remains unstudied. In this study, we used a geographically defined, fully representative PBC patient cohort to study the prevalence of symptoms of autonomic dysfunction and its relationship with other symptoms of PBC. Symptoms of cardiovascular autonomic dysfunction (as assessed using the Orthostatic Grading Scale [OGS]) were significantly more frequently reported and significantly more severe in PBC patients than in both matched normal controls (40% versus 6% with moderate or worse orthostasis (P < .0001), mean OGS score 3.2 ؎ 3.4 versus 1.3 ؎ 1.9, P < .005) and in patients with primary sclerosing cholangitis and in severity were independently associated with severity of fatigue and cognitive symptoms (both r 2 ؍ 0.3, P < .0001). Thirteen of 20 patients with an OGS value > 4 (moderate severity and worse) had significant abnormality in autonomic regulation of blood pressure, which was identified on dynamic testing. Conclusion: Symptoms suggestive of autonomic dysfunction frequently occur in PBC patients and reflect dysregulation of actual blood pressure. Autonomic dysfunction is independently associated with both fatigue and, importantly, symptoms of cognitive dysfunction, suggesting the potential for significant organic sequelae. (HEPATOLOGY 2007;45:1496-1505.) P rimary biliary cirrhosis (PBC) is a chronic cholestatic liver disease affecting up to 1 in 700 women over the age of 40 in western European populations. 1 It has become widely accepted in the last few years that this condition is characterized by profound fatigue that can often significantly impair quality of life. [2][3][4][5][6] The severity of fatigue experienced by PBC patients appears to be unrelated to the degree of hepatocellular dysfunction. 3,4,6 Studies using animal models of cholestasis (exemplified by the bile duct ligated rodent) have suggested that fatigue results from a combination of the biochemical and inflammatory consequences of cholestasis development. 7-10 Studies using these animal models have further suggested that the processes responsible for fatigue pathogenesis are mediated in the central nervous system. More limited studies performed in human PBC patients have indicated the likelihood that central nervous system-mediated processes are similarly important in fatigue pathogenesis in human cholestatic subjects. 11,12 Despite increasing appreciation of the importance of fatigue in the experience of PBC patients and localization of key pathogenetic processes to the central nervous system, the understanding of the precise mechanisms responsible for fatigue ex...